Oct 28: ANDREW WITTY on the financial crisis

In the first part of this week's View from the Top, Andrew Witty, chief executive of GlaxoSmithKline, tells Richard Milne that the global financial crisis has not had a big impact on the pharmaceuticals industry but Mr Witty does expect some increased price pressure from governments. Mr Witty also explains why GSK has slowed down its share buy-back programme.